Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polypharmacy and Delirium in Critically Ill Children
NCT03293927Phase 2Withdrawn
- Sponsor
- Duke University
- Start
- Apr 2018
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of fentanyl and dexmedetomidine in delirium (4 arms), sponsored by Duke University. Primary endpoint: Cornell Assessment of Pediatric Delirium at 10 days. Planned start Apr 2018; status: withdrawn.
02
Drugs
fentanyldexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT03293927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03293927.